A diagnostic test kit for detecting the Factor II mutation (G20210A) associated with increased thrombotic risk. The kit contains reagents for 32 tests and is compatible with QiaSymphony SP/AP extraction systems. It is CE Mark certified.
Manufactured by
CLONIT SRL
Abbiategrasso, Italy
Since 1987, Clonit has been focused in developing, manufacturing and distributing of innovative and reliable in Vitro Diagnostic Equipment and Reagents for Molecular Diagnostics. A deep expertise in Molecular Biology mixed to our strong culture of business ethics make our company a valued partner for laboratories and hospitals around the world. With our high standard and high performance IVDs portfolio, we aim to improve healthcare by enhancing and supporting the decision-making process, in line with scientific and technological evolution. Our clinical diagnostic products are used to detect a broad range of diseases in several key areas such as viral, bacterial and fungal infections (including sexually transmitted diseases, transplantation/immunocompromised related infections, tropical diseases, healthcare associated infections), thrombophilia, oncohematology and several genetic disorders . The standardization of internal quality control system and cross-checks in external reference labs allow Clonit to ensure application of the highest standards of care and quality (ISO 9001 and ISO 13485 Certified). Recently Clonit obtained the certification of products according to EU 2017/746 Regulation on In Vitro Diagnostic Medical Devices (IVDR). Certification for Class C products was issued by TÜV SÜD Product Service The company is registered and authorized by the Italian Ministry of the Health for the development, manufacturing and commercialization of Medical Diagnostic devices. We listen carefully to our customers’ needs and work closely with health care professionals to transform them into solutions that provide people a better quality of life.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Advanced Molecular Diagnostics Ltd.
United Kingdom · 5 relevant products
GENERI BIOTECH s.r.o.
Czech Republic · 4 relevant products
Attomol GmbH - Molekulare Diagnostika
Germany · 21 relevant products
36 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 21 relevant matches
GMA Group Trading · Egypt
Molecular test for detecting thrombophilia-related genetic mutations in coagulation factors F2 and F5.
Attomol GmbH - Molekulare Diagnostika · Germany
A diagnostic test kit for detecting the Prothrombin mutation (Factor II 20210G>A). The kit is designed for molecular genetic analysis and contains 40 test determinations. This test is used to identify genetic variations associated with increased thrombotic risk.
Attomol GmbH - Molekulare Diagnostika · Germany
A diagnostic test kit for detecting the Prothrombin mutation (Factor II 1991 1A>G). The kit contains 20 test determinations and is used for molecular genetic screening of this factor II variant.
18 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products